SUPRIYA Share Price Performance
₹0
-726.00 (-100.00%)
Price ₹0
Fair Value₹940.00
Share Pricen/a
Narrative Update • Jun 16
Supriya Lifescience Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
SUPRIYA Community Narratives
AN
Fair Value
·Fair Value ₹940 4.1% overvalued intrinsic discount
Backward Integration And India Sourcing Will Drive Resilient Manufacturing
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Backward Integration And India Sourcing Will Drive Resilient Manufacturing
A drug-ingredient maker in India looks set to ride the global move away from China, using more in-house production and upgraded factories to keep supply steady and defend profits. The bigger question is whether its next wave of new products and overseas approvals lands on time—or whether export and regulation shocks hit first.Read more
AN
₹940
4.1% overvalued intrinsic discount
Fair Value
Revenue
23.31% p.a.
Profit Margin
25.72%
Future PE
26.82x
Price in 2029
₹1.33k
Trending Discussion
Recently Updated Narratives
AN
SUPRIYA: USFDA VAI Outcome And Exports Will Shape Balanced Stock Outlook
Fair Value: ₹940 4.1% overvalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Supriya Lifescience Limited Key Details
About SUPRIYA
- Founded
- 1987
- Employees
- 515
- CEO
- WebsiteView website
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
